Use of Magnesium in Traumatic Brain Injury

Neurotherapeutics

Volumn 7, Issue 1, 2010, Pages 91-99

  Sen, Ananda P ^a   Gulati, Anil ^b  

^a EndogenX   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

hyperoxia; hypothermia; magnesium; neuroprotection; Traumatic brain injury

Indexed keywords

ANTIOXIDANT; CYCLOSPORIN A; DEXANABINOL; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIDOCAINE; MAGNESIUM; MANNITOL; MINOCYCLINE; NEUROPROTECTIVE AGENT; PROGESTERONE; PROTIRELIN DERIVATIVE; RIBOFLAVIN; TIRILAZAD; TOLL LIKE RECEPTOR AGONIST;

ARTICLE; BIOAVAILABILITY; BIOCHEMISTRY; BLOOD TOXICITY; BRAIN; BRAIN ISCHEMIA; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPEROXIA; HYPOTHERMIA; INDUCED HYPOTHERMIA; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ANIMALS; BRAIN; BRAIN INJURIES; HUMANS; MAGNESIUM; NEUROPROTECTIVE AGENTS;

EID: 72949093090     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2009.10.014     Document Type: Article

References (98)

1. Temkin N.R., Anderson G.D., Winn H.R., et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 6 (2007) 29-38
2. Dhandapani S.S., Gupta A., Vivekanandhan S., Sharma B.S., and Mahapatra A.K. Randomized controlled trial of magnesium sulphate in severe closed traumatic brain injury. Indian J Neurotrauma 5 (2008) 27-33
3. Hallak M., Berman R.F., Irtenkauf S.M., Evans M.I., and Cotton D.B. Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am J Obstet Gynecol 167 (1992) 1605-1610
4. Hoane M.R. Assessment of cognitive function following magnesium therapy in the traumatically injured brain. Magnes Res 20 (2007) 229-236
5. Fuchs-Buder T., Tramèr M.R., and Tassonyi E. Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. J Neurosurg Anesthesiol 9 (1997) 324-328
6. McKee J.A., Brewer R.P., Macy G.E., et al. Analysis of the brain bioavailability of peripherally administered magnesium sulfate: a study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med 33 (2005) 661-666
7. Thurnau G.R., Kemp D.B., and Jarvis A. Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 157 (1987) 1435-1438
8. Stoica B., Byrnes K., and Faden A.I. Multifunctional drug treatment in neurotrauma. Neurotherapeutics 6 (2009) 14-27
9. Vink R., and Nimmo A.J. Multifunctional drugs for head injury. Neurotherapeutics 6 (2009) 28-42
10. Maas A.I., Murray G., Henney III H., et al. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol 5 (2006) 38-45
11. Bouma G.J., Muizelaar J.P., Choi S.C., Newlon P.G., and Young H.F. Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia. J Neurosurg 75 (1991) 685-693
12. Jenkins L.W., Moszynski K., Lyeth B.G., et al. Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: the use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury. Brain Res 477 (1989) 211-224
13. Bergsneider M., Hovda D.A., Shalmon E., et al. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg 86 (1997) 241-251
14. Goodman J.C., Valadka A.B., Gopinath S.P., Uzura M., and Robertson C.S. Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis. Crit Care Med 27 (1999) 1965-1973
15. Enblad P., Valtysson J., Andersson J., et al. Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab 16 (1996) 637-644
16. Persson L., Valtysson J., Enblad P., et al. Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg 84 (1996) 606-616
17. Stocchetti N., Colombo A., Ortolano F., et al. Time course of intracranial hypertension after traumatic brain injury. J Neurotrauma 24 (2007) 1339-1346
18. Balestreri M., Czosnyka M., Hutchinson P., et al. Impact of intracranial pressure and cerebral perfusion pressure on severe disability and mortality after head injury. Neurocrit Care 4 (2006) 8-13
19. Obrenovitch T.P., and Urenjak J. Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?. J Neurotrauma 14 (1997) 677-698
20. Fiskum G. Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma 17 (2000) 843-855
21. Lifshitz J., Friberg H., Neumar R.W., et al. Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus. J Cereb Blood Flow Metab 23 (2003) 219-231
22. van den Heuvel C., and Vink R. The role of magnesium in traumatic brain injury. Clin Calcium 14 (2004) 9-14
23. Garfinkel L., and Garfinkel D. Magnesium regulation of the glycolytic pathway and the enzymes involved. Magnesium 4 (1985) 60-72
24. Altura B.M., and Altura B.T. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc 40 (1981) 2672-2679
25. Hans C.P., Chaudhary D.P., and Bansal D.D. Magnesium deficiency increases oxidative stress in rats. Indian J Exp Biol 40 (2002) 1275-1279
26. Garcia L.A., Dejong S.C., Martin S.M., Smith R.S., Buettner G.R., and Kerber R.E. Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model. J Am Coll Cardiol 32 (1998) 536-539
27. Cernak I., Savic V.J., Kotur J., Prokic V., Veljovic M., and Grbovic D. Characterization of plasma magnesium concentration and oxidative stress following graded traumatic brain injury in humans. J Neurotrauma 17 (2000) 53-68
28. Chan M.T., Boet R., Ng S.C., Poon W.S., and Gin T. Magnesium sulfate for brain protection during temporary cerebral artery occlusion. Acta Neurochir Suppl 95 (2005) 107-111
29. Napieralski J.A., Raghupathi R., and McIntosh T.K. The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res Mol Brain Res 71 (1999) 78-86
30. Lee J.S., Han Y.M., Yoo D.S., et al. A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats. J Neurotrauma 21 (2004) 549-561
31. Nielsen S., Nagelhus E.A., Amiry-Moghaddam M., Bourque C., Agre P., and Ottersen O.P. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17 (1997) 171-180
32. Ghabriel M.N., Thomas A., and Vink R. Magnesium restores altered aquaporin-4 immunoreactivity following traumatic brain injury to a pre-injury state. Acta Neurochir Suppl 96 (2006) 402-406
33. Okiyama K., Smith D.H., Gennarelli T.A., Simon R.P., Leach M., and McIntosh T.K. The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J Neurochem 64 (1995) 802-809
34. Heath D.L., and Vink R. Concentration of brain free magnesium following severe brain injury correlates with neurologic motor outcome. J Clin Neurosci 6 (1999) 505-509
35. Bareyre F.M., Saatman K.E., Helfaer M.A., et al. Alterations in ionized and total blood magnesium after experimental traumatic brain injury: relationship to neurobehavioral outcome and neuroprotective efficacy of magnesium chloride. J Neurochem 73 (1999) 271-280
36. Feldman Z., Gurevitch B., Artru A.A., et al. Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. J Neurosurg 85 (1996) 131-137
37. 4 attenuates long-term hippocampal tissue loss after brain trauma in the rat. J Neurosci Res 77 (2004) 878-883
38. Hoane M.R. Magnesium therapy and recovery of function in experimental models of brain injury and neurodegenerative disease. Clin Calcium 14 (2004) 65-70
39. Hoane M.R., Knotts A.A., Akstulewicz S.L., Aquilano M., and Means L.W. The behavioral effects of magnesium therapy on recovery of function following bilateral anterior medial cortex lesions in the rat. Brain Res Bull 60 (2003) 105-114
40. Heath D.L., and Vink R. Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. J Pharmacol Exp Ther 288 (1999) 1311-1316
41. Bareyre F.M., Saatman K.E., Raghupathi R., and McIntosh T.K. Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats. J Neurotrauma 17 (2000) 1029-1039
42. Heath D.L., and Vink R. Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats. J Neurosurg 90 (1999) 504-509
43. Hoane M.R., and Barth T.M. The window of opportunity for administration of magnesium therapy following focal brain injury is 24 h but is task dependent in the rat. Physiol Behav 76 (2002) 271-280
44. Vink R., O'Connor C.A., Nimmo A.J., and Heath D.L. Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats. Neurosci Lett 336 (2003) 41-44
45. Heath D.L., and Vink R. Subdural hematoma following traumatic brain injury causes a secondary decline in brain free magnesium concentration. J Neurotrauma 18 (2001) 465-469
46. Kahraman S., Ozgurtas T., Kayali H., Atabey C., Kutluay T., and Timurkaynak E. Monitoring of serum ionized magnesium in neurosurgical intensive care unit: preliminary results. Clin Chim Acta 334 (2003) 211-215
47. Memon Z.I., Altura B.T., Benjamin J.L., Cracco R.Q., and Altura B.M. Predictive value of serum ionized but not total magnesium levels in head injuries. Scand J Clin Lab Invest 55 (1995) 671-677
48. Polderman K.H., Bloemers F.W., Peerdeman S.M., and Girbes A.R. Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury. Crit Care Med 28 (2000) 2022-2025
49. Sakamoto T., Takasu A., Saitoh D., Kaneko N., Yanagawa Y., and Okada Y. Ionized magnesium in the cerebrospinal fluid of patients with head injuries. J Trauma 58 (2005) 1103-1109
50. Kafadar A.M., Sanus G.Z., Is M., et al. Prolonged elevation of magnesium in the cerebrospinal fluid of patients with severe head injury. Neurol Res 29 (2007) 824-829
51. Canavero S., Bonicalzi V., and Narcisi P. Safety of magnesium-lidocaine combination for severe head injury: the Turin Lidomag Pilot Study. Surg Neurol 60 (2003) 165-169
52. Natale J.E., Guerguerian A.M., Joseph J.G., et al. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury. Pediatr Crit Care Med 8 (2007) 1-9
53. Mosenthal A.C., Livingston D.H., Lavery R.F., et al. The effect of age on functional outcome in mild traumatic brain injury: 6-month report of a prospective multicenter trial. J Trauma 56 (2004) 1042-1048
54. Livingston D.H., Lavery R.F., Mosenthal A.C., et al. Recovery at one year following isolated traumatic brain injury: a Western Trauma Association prospective multicenter trial. J Trauma 59 (2005) 1298-1304
55. Chesnut R.M., Marshall L.F., Klauber M.R., et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 34 (1993) 216-222
56. Newfield P., Pitts L., Kaktis J., and Hoff J. The influence of shock on mortality after head trauma. Crit Care Med 8 (1980) 254 (abstract)
57. Manley G., Knudson M.M., Morabito D., Damron S., Erickson V., and Pitts L. Hypotension, hypoxia, and head injury: frequency, duration, and consequences. Arch Surg 136 (2001) 1118-1123
58. Rovlias A., and Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46 (2000) 335-342 discussion 342-343
59. Laird A.M., Miller P.R., Kilgo P.D., Meredith J.W., and Chang M.C. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 56 (2004) 1058-1062
60. Walia S., and Sutcliffe A.J. The relationship between blood glucose, mean arterial pressure and outcome after severe head injury: an observational study. Injury 33 (2002) 339-344
61. Bochicchio G.V., Joshi M., Bochicchio K.M., et al. Early hyperglycemic control is important in critically injured trauma patients. J Trauma 63 (2007) 1353-1358
62. Zygun D.A., Kortbeek J.B., Fick G.H., Laupland K.B., and Doig C.J. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med 33 (2005) 654-660
63. Jeremitsky E., Omert L., Dunham C.M., Protetch J., and Rodriguez A. Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion. J Trauma 54 (2003) 312-319
64. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., and Reulen H.J. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia. Neurosurgery 44 (1999) 163-171
65. Barbre A.B., and Hoane M.R. Magnesium and riboflavin combination therapy following cortical contusion injury in the rat. Brain Res Bull 69 (2006) 639-646
66. Eshhar N., Striem S., Kohen R., Tirosh O., and Biegon A. Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist. Eur J Pharmacol 283 (1995) 19-29
67. Feigenbaum J.J., Bergmann F., Richmond S.A., et al. Nonpsychotropic cannabinoid acts as a functional N-methyl-d-aspartate receptor blocker. Proc Natl Acad Sci U S A 86 (1989) 9584-9587
68. Shohami E., Gallily R., Mechoulam R., Bass R., and Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant. J Neuroimmunol 72 (1997) 169-177
69. Knoller N., Levi L., Shoshan I., et al. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. Crit Care Med 30 (2002) 548-554
70. Ogata T., Nakamura Y., Tsuji K., Shibata T., and Kataoka K. Steroid hormones protect spinal cord neurons from glutamate toxicity. Neuroscience 55 (1993) 445-449
71. Roof R.L., Hoffman S.W., and Stein D.G. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol 31 (1997) 1-11
72. O'Connor C.A., Cernak I., and Vink R. Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats. Brain Res 1062 (2005) 171-174
73. Pettus E.H., Wright D.W., Stein D.G., and Hoffman S.W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 1049 (2005) 112-119
74. O'Connor C.A., Cernak I., Johnson F., and Vink R. Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats. Exp Neurol 205 (2007) 145-153
75. Wright D.W., Kellermann A.L., Hertzberg V.S., et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49 (2007) 391-402
76. Xiao G., Wei J., Yan W., Wang W., and Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 12 (2008) R61
77. Zhu H., Meloni B.P., Bojarski C., Knuckey M.W., and Knuckey N.W. Post-ischemic modest hypothermia (35°C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats. Exp Neurol 193 (2005) 361-368
78. Campbell K., Meloni B.P., and Knuckey N.W. Combined magnesium and mild hypothermia (35°C) treatment reduces infarct volumes after permanent middle cerebral artery occlusion in the rat at 2 and 4, but not 6 h. Brain Res 1230 (2008) 258-264
79. Schmid-Elsaesser R., Hungerhuber E., Zausinger S., Baethmann A., and Reulen H.J. Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia. Stroke 30 (1999) 1891-1899
80. Zausinger S., Schöller K., Plesnila N., and Schmid-Elsaesser R. Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats. Stroke 34 (2003) 2246-2251
81. Jiang J., Yu M., and Zhu C. Effect of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-year follow-up review of 87 cases. J Neurosurg 93 (2000) 546-549
82. Qiu W., Zhang Y., Sheng H., et al. Effects of therapeutic mild hypothermia on patients with severe traumatic brain injury after craniotomy. J Crit Care 22 (2007) 229-235
83. Smrcka M., Vidlák M., Máca K., Smrcka V., and Gál R. The influence of mild hypothermia on ICP, CPP and outcome in patients with primary and secondary brain injury. Acta Neurochir Suppl 95 (2005) 273-275
84. Marion D.W., Penrod L.E., Kelsey S.F., et al. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 336 (1997) 540-546
85. Clifton G.L., Miller E.R., Choi S.C., et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 344 (2001) 556-563
86. Shiozaki T., Hayakata T., Taneda M., et al., Mild Hypothermia Study Group in Japan. A multicenter prospective randomized controlled trial of the efficacy of mild hypothermia for severely head injured patients with low intracranial pressure. J Neurosurg 94 (2001) 50-54
87. Bayir H., Adelson P.D., Wisniewski S.R., et al. Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children. [Erratum in: Crit Care Med 2009;37:1536]. Crit Care Med 37 (2009) 689-695
88. Peterson K., Carson S., and Carney N. Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma 25 (2008) 62-71
89. Bullock M.R. Hyperoxia: good or bad?. J Neurosurg 98 (2003) 943-944
90. Tisdall M.M., Tachtsidis I., Leung T.S., Elwell C.E., and Smith M. Increase in cerebral aerobic metabolism by normobaric hyperoxia after traumatic brain injury. J Neurosurg 109 (2008) 424-432
91. Rockswold S.B., Rockswold G.L., Vargo J.M., et al. Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. J Neurosurg 94 (2001) 403-411
92. Nortje J., Coles J.P., Timofeev I., et al. Effect of hyperoxia on regional oxygenation and metabolism after severe traumatic brain injury: preliminary findings. Crit Care Med 36 (2008) 273-281
93. Diringer M.N., Aiyagari V., Zazulia A.R., Videen T.O., and Powers W.J. Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury. J Neurosurg 106 (2007) 526-529
94. Menzel M., Doppenberg E.M., Zauner A., Soukup J., Reinert M.M., and Bullock R. Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. J Neurosurg 91 (1999) 1-10
95. Reinert M., Barth A., Rothen H.U., Schaller B., Takala J., and Seiler R.W. Effects of cerebral perfusion pressure and increased fraction of inspired oxygen on brain tissue oxygen, lactate and glucose in patients with severe head injury. Acta Neurochir (Wien) 145 (2003) 341-349 discussion 349-350
96. Tolias C.M., Reinert M., Seiler R., Gilman C., Scharf A., and Bullock M.R. Normobaric hyperoxia-induced improvement in cerebral metabolism and reduction in intracranial pressure in patients with severe head injury: a prospective historical cohort-matched study. J Neurosurg 101 (2004) 435-444
97. Jenkinson S.G. Oxygen toxicity. New Horiz 1 (1993) 504-511
98. Bulte D.P., Chiarelli P.A., Wise R.G., and Jezzard P. Cerebral perfusion response to hyperoxia. J Cereb Blood Flow Metab 27 (2007) 69-75